“We started coming to Israel during the Intifada when no one else was coming here,” Bob Grossman, principle shareholder and co-chair of the Israeli Practice Group at Greenberg Traurig told The Jerusalem Post. “Because there is so much technology and promise here, we felt it was a good time to come both from a business perspective and because it was the right thing to do.”
Today the firm, which has a global network of over 30,000 clients, does legal work for well over 50 Israeli companies and has relationships with “literally hundreds of others,” Grossman added.
He explained that the focus of the company’s activity in Israel has been on services beyond that of the lawyer-client relationship and has grown through matching local companies with strategic partners abroad and increasing its networking base.
This strategy led the firm to participate in last week’s third annual life sciences mission run by Global Capital Associates, which brought potential investors and business partners from the US to meet with the Israeli life sciences market.
Co-hosting the mission was former US attorney-general John Ashcroft and former secretary of the US Department of Health and Human Services Tommy Thompson, who were both honored during their stay for their support for Israel.
